According to the Centers for Disease Control and Prevention, there is no link between vaccines and autism. As a father of two children, I don’t just believe that to be true but accept it as such. The Cdc’s scientific evidence is strong enough, and both my kids have been vaccinated. They will continue to be vaccinated. It’s not a matter of majority public opinion. The data and facts are there. That said, I’m interested in all points of view, whether well-argued or based on conjecture. I watch a ton of documentaries. I especially like those with contrarian perspectives. If most weren’t so badly made, I’d see all the films that directly respond to popular films, like An Inconsistent Truth. At Nonfics, I always recommend Netflix subscribers stream FrackNation as a double feature with GasLand. So, I was conflicted last week when the Tribeca Film Festival was defending its decision to program...
- 3/28/2016
- by Christopher Campbell
- FilmSchoolRejects.com
Old action heroes prove they can still entertain while anti-Obama documentary becomes box-office phenomenon
Audiences clearly have a taste for Lionsgate's action masala The Expendables 2, which contained enough spice to stay atop the Us charts for the second consecutive weekend. I said last week that the sight of Sly Stallone and Arnold Schwarzenegger shooting holes in the landscape after all these years says all you need to know about the dearth of marketable A-list action heroes today, but you've got to hand it to them – it appears the old dogs can still entertain.
Good to see Universal's fourth Bourne thriller taking strides towards the $100m mark. Jeremy Renner has fitted into the franchise seamlessly with his quiet intensity and superior acting chops and The Bourne Legacy should pass the milestone by next weekend, which will be its fourth in release.
ParaNorman has grossed $28.3m after two weekends. It's a...
Audiences clearly have a taste for Lionsgate's action masala The Expendables 2, which contained enough spice to stay atop the Us charts for the second consecutive weekend. I said last week that the sight of Sly Stallone and Arnold Schwarzenegger shooting holes in the landscape after all these years says all you need to know about the dearth of marketable A-list action heroes today, but you've got to hand it to them – it appears the old dogs can still entertain.
Good to see Universal's fourth Bourne thriller taking strides towards the $100m mark. Jeremy Renner has fitted into the franchise seamlessly with his quiet intensity and superior acting chops and The Bourne Legacy should pass the milestone by next weekend, which will be its fourth in release.
ParaNorman has grossed $28.3m after two weekends. It's a...
- 8/27/2012
- by Jeremy Kay
- The Guardian - Film News
Each Tuesday, Indiewire publishes a box office chart that sorts the final weekend numbers of all specialty releases by per-theater average. You can check out the full chart here, but here are some highlights: Top Per-Theater Average and Best Debut: "2016 Obama's America" (Rocky Mountain Pictures) The anti-Barack Obama documentary “2016: Obama’s America" -- written and directed by John Sullivan and “The Roots of Obama’s Rage” author Dinesh D’Souza -- hits theaters nationwide on July 27 (via Rocky Mountain Pictures, or the same folks that brought you "Atlas Shrugged, Part I" and "An Inconsistent Truth"). But it opened on a single Houston screen first this past weekend, and managed a very impressive $31,750 -- by far the highest per-theater-average of any film in release. It remains to be seen whether it can pull in relatively decent numbers outside Republican hotbeds like Texas, but we'll find out...
- 7/17/2012
- by Peter Knegt
- Indiewire
IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news articles, Tweets, and blog posts do not represent IMDb's opinions nor can we guarantee that the reporting therein is completely factual. Please visit the source responsible for the item in question to report any concerns you may have regarding content or accuracy.